홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Carbonate → 2-{[Bis(benzyloxy)phosphoryl]oxy}ethyl 1-ethyl-6-{6-[(ethylcarbamoyl)amino]-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyridin-3-yl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate

HRID 1047121
인쇄

반응식

HRID 1047121 반응식
Br[C:2]1[CH:3]=[C:4]2[C:9](=[N:10][CH:11]=1)[N:8]([CH2:12][CH3:13])[CH:7]=[C:6]([C:14]([O:16][CH2:17][CH2:18][O:19][P:20]([O:30][CH2:31][C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1)([O:22][CH2:23][C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)=[O:21])=[O:15])[C:5]2=[O:38].[CH2:39]([NH:41][C:42](=[O:62])[NH:43][C:44]1[N:49]=[CH:48][C:47](B(O)O)=[C:46]([C:53]2[S:54][CH:55]=[C:56]([C:58]([F:61])([F:60])[F:59])[N:57]=2)[CH:45]=1)[CH3:40].C(=O)([O-])[O-].[Na+].[Na+]>CN(C)C=O.[Pd].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>[CH2:12]([N:8]1[C:9]2[C:4](=[CH:3][C:2]([C:47]3[CH:48]=[N:49][C:44]([NH:43][C:42](=[O:62])[NH:41][CH2:39][CH3:40])=[CH:45][C:46]=3[C:53]3[S:54][CH:55]=[C:56]([C:58]([F:61])([F:59])[F:60])[N:57]=3)=[CH:11][N:10]=2)[C:5](=[O:38])[C:6]([C:14]([O:16][CH2:17][CH2:18][O:19][P:20]([O:30][CH2:31][C:32]2[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=2)([O:22][CH2:23][C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)=[O:21])=[O:15])=[CH:7]1)[CH3:13]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 10340Sodium CarbonateHCID 594161896-(3-Ethylureido)-4-(4-(trifluoromethyl)thiazol-2-yl)pyridin-3-ylboronic acid2회HCID 687488382-{[Bis(benzyloxy)phosphoryl]oxy}ethyl 6-bromo-1-ethyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate2회

생성물 1

HCID 687481932-{[Bis(benzyloxy)phosphoryl]oxy}ethyl 1-ethyl-6-{6-[(ethylcarbamoyl)amino]-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyridin-3-yl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate
수율 63%

시약·촉매·용매 2

HCID 11979704Tetrakis(triphenylphosphine)palladium촉매HCID 6228Dimethylformamide용매

실험 절차

2-{[Bis(benzyloxy)phosphoryl]oxy}ethyl 6-bromo-1-ethyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate (Intermediate 25, 80 mg, 0.133 mmol) was dissolved in dimethylformamide (15 mL), and the solution was purged with argon. Tetrakis (triphenylphosphine) palladium (15 mg, 0.013 mmol) and 6-(3-ethylureido)-4-(4-(trifluoromethyl)thiazol-2-yl)pyridin-3-ylboronic acid (Intermediate 9, 71 mg, 0.16 mmol) were added and the mixture was stirred for 20 min at room temperature. Sodium carbonate solution (57 mg, 0.53 mmol) (dissolved in minimum amount of water) was added, and the reaction mixture was heated to 90° C. for 3 h. The reaction mixture was passed through celite and the celite was washed with dimethylformamide. The dimethylformamide layer was poured into water (100 mL) and a precipitate formed. The solid was filtered and dried then purified by flash column chromatography over silica gel (0-8% MeOH/CHCl3) to afford 70 mg (63%) of 2-{[bis(benzyloxy)phosphoryl]oxy}ethyl 1-ethyl-6-{6-[(ethylcarbamoyl)amino]-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]pyridin-3-yl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate as white solid.

후처리

  1. customthe solution was purged with argon
  2. temperaturethe reaction mixture was heated to 90° C. for 3 h
  3. washthe celite was washed with dimethylformamide
  4. additionThe dimethylformamide layer was poured into water (100 mL)
  5. customa precipitate formed
  6. filtrationThe solid was filtered
  7. customdried
  8. customthen purified by flash column chromatography over silica gel (0-8% MeOH/CHCl3)

출처 및 근거

ORD 기록
ord-611a45d3276645dc96f88f0e5c917e37
출처 데이터셋
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08569484B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트